| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 11 1535-1544, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
JM Turley, LA Falk, FW Ruscetti, JJ Kasper, T Francomano, T Fu, OS Bang and MC Birchenall-Roberts
Laboratory of Leukocyte Biology, National Cancer Institute, Frederick, Maryland 21702, USA.
This study examined the role of transforming growth factor beta 1 (TGF-beta 1) in monocytic differentiation of hematopoietic cells. TGF-beta 1 and retinoic acid (RA) inhibited HL-60 cell growth in a dose-dependent fashion. Treatment of HL-60 cells with a combination of TGF-beta 1 and a 50% optimal dose of RA (RA + TGF-beta 1) resulted in increased growth suppression compared to the individual treatments. Morphological studies revealed that TGF-beta 1 induced promonocytic differentiation (68%), RA induced granulocytic differentiation (98%), and RA + TGF-beta 1 induced monocytic (54%) and granulocytic (46%) differentiation of HL-60 cells. Induction of the monocyte-specific marker, nonspecific esterase, was markedly increased by TGF-beta 1 and RA + TGF-beta 1 treatment but not by RA treatment. Both TGF-beta 1 treatment and RA treatment increased TGF-beta ligand and TGF-beta receptor protein and mRNA levels. To determine whether RA mediated HL-60 cell growth inhibition and differentiation through the autocrine expression of TGF-beta 1, experiments using TGF-beta 1 antisense oligonucleotides or TGF-beta 1-neutralizing antibodies were conducted. TGF-beta 1 antisense oligonucleotides and neutralizing antibodies partially blocked RA-induced inhibition of proliferation, and TGF-beta 1 antisense oligonucleotides reversed RA-induced granulocytic maturation, demonstrating that RA signals autocrine expression of TGF-beta 1 and TGF-beta receptors. The effect of TGF-beta 1 on normal hematopoiesis was also studied using primary human fetal liver cells. TGF-beta 1 alone and in the presence of interleukin 3 promoted macrophage differentiation of primitive fetal liver cells. Cell surface expression of the monocyte/macrophage-specific marker c-fms was increased 3.1-fold following TGF-beta 1 treatment. In addition, TGF-beta 1-treated cells displayed a 51% increase in phagocytosis as compared to interleukin 3-treated control cells. These studies define a role for TGF-beta 1 in the autocrine and paracrine regulation of monocyte/macrophage differentiation.
This article has been cited by other articles:
![]() |
C. Soo, S. R. Beanes, F.-Y. Hu, X. Zhang, C. Dang, G. Chang, Y. Wang, I. Nishimura, E. Freymiller, M. T. Longaker, et al. Ontogenetic Transition in Fetal Wound Transforming Growth Factor-{beta} Regulation Correlates with Collagen Organization Am. J. Pathol., December 1, 2003; 163(6): 2459 - 2476. [Abstract] [Full Text] |
||||
![]() |
Z. Cao, K. C. Flanders, D. Bertolette, L. A. Lyakh, J. U. Wurthner, W. T. Parks, J. J. Letterio, F. W. Ruscetti, and A. B. Roberts Levels of phospho-Smad2/3 are sensors of the interplay between effects of TGF-beta and retinoic acid on monocytic and granulocytic differentiation of HL-60 cells Blood, January 15, 2003; 101(2): 498 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Brown and N. R. Kamal The Reed-Sternberg Cell: Molecular Characterization by Proteomic Analysis with Therapeutic Implications Ann. Clin. Lab. Sci., October 1, 2002; 32(4): 339 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Wicke, B. Halliday, D. Allen, N. S. Roche, H. Scheuenstuhl, M. M. Spencer, A. B. Roberts, and T. K. Hunt Effects of Steroids and Retinoids on Wound Healing Arch Surg, November 1, 2000; 135(11): 1265 - 1270. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis Blood, September 15, 2000; 96(6): 2022 - 2036. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Batard, M. Monier, N Fortunel, K Ducos, P Sansilvestri-Morel, T Phan, A Hatzfeld, and J. Hatzfeld TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation J. Cell Sci., January 2, 2000; 113(3): 383 - 390. [Abstract] [PDF] |
||||
![]() |
L. E. Purton, I. D. Bernstein, and S. J. Collins All-Trans Retinoic Acid Delays the Differentiation of Primitive Hematopoietic Precursors (lin-c-kit+Sca-1+) While Enhancing the Terminal Maturation of Committed Granulocyte/Monocyte Progenitors Blood, July 15, 1999; 94(2): 483 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.P. Kale and L.S. Limaye Stimulation of Adult Human Bone Marrow by Factors Secreted by Fetal Liver Hematopoietic Cells: In Vitro Evaluation Using Semisolid Clonal Assay System Stem Cells, March 1, 1999; 17(2): 107 - 116. [Abstract] [Full Text] |
||||
![]() |
S. Kim, O. Bang, Y. Lee, and S. Kang Production of inducible nitric oxide is required for monocytic differentiation of U937 cells induced by vitamin E-succinate J. Cell Sci., January 2, 1998; 111(4): 435 - 441. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |